Codexis and Molecular Assemblies Partner to Transform the Field of DNA Synthesis
June 23, 2020 07:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif. and SAN DIEGO, June 23, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company and developer of high-performance enzymes, and Molecular...
Codexis Announces the Election of New Directors at its Annual Meeting of Stockholders
June 16, 2020 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., June 16, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company and developer of high-performance enzymes, announces the election of new...
Codexis and Alphazyme Partner to Offer Novel Enzymes to Life Science and Diagnostic Markets
June 01, 2020 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif. and JUPITER, Fla., June 01, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company and developer of high-performance enzymes, and Alphazyme...
Codexis to Participate in Two Virtual Investment Conferences
May 27, 2020 07:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., May 27, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces that management will participate in two virtual investment...
Codexis to Present at the UBS Virtual Healthcare Conference
May 11, 2020 07:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., May 11, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces that management will present at the UBS Virtual Healthcare...
Codexis Reports First Quarter 2020 Financial Results
May 07, 2020 16:05 ET
|
Codexis, Inc.
R&D revenue increased 26% to $9.6 million fueled by the Novartis and Takeda strategic collaborations Withdraws 2020 financial guidance due to uncertainty of COVID-19 potential impact Conference...
Codexis Achieves Technology Transfer Milestone with Global Pharmaceutical Leader
May 06, 2020 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., May 06, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc., a leading protein engineering company and developer of novel biotherapeutics, announces achievement of the Wave 2 milestone...
Codexis Expands and Strengthens its Leadership Team with Two Executive Hires
May 05, 2020 07:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., May 05, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc., a leading protein engineering company and developer of novel biotherapeutics, announces the appointment of Stefan Lutz, Ph.D. as...
Codexis to Hold First Quarter 2020 Conference Call on May 7
April 30, 2020 07:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., April 30, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that it will report first quarter 2020 financial results after...
Codexis Reports 2019 Fourth Quarter and Full Year Financial Results
February 27, 2020 16:05 ET
|
Codexis, Inc.
2019 total revenues increased 13% to $68.5 million with product revenue up 15% and R&D revenue up 11% Ten customers contributed more than $1 million each to 2019 revenues Introduces...